Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-11-2022 | Hodgkin Lymphoma | Case report

Multiple drugs

Myeloproliferative disorder, Hodgkin's lymphoma and kidney cancer: 3 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Mariottini A, et al. Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis. European Journal of Neurology 29: 1708-1718, No. 6, Jun 2022. Available from: URL: http://doi.org/10.1111/ene.15280 Mariottini A, et al. Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis. European Journal of Neurology 29: 1708-1718, No. 6, Jun 2022. Available from: URL: http://​doi.​org/​10.​1111/​ene.​15280
Metadata
Title
Multiple drugs
Myeloproliferative disorder, Hodgkin's lymphoma and kidney cancer: 3 case reports
Publication date
01-11-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-27230-7

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Multiple drugs

Case report

Catequentinib

Case report

Mepolizumab

Case report

Antineoplastics

Case report

Aripiprazole